Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inotropic agents. Catecholamines, digoxin, amrinone.

D A Notterman1

  • 1Cornell University Medical College, New York, New York.

Critical Care Clinics
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matrices.

Bioinformatics (Oxford, England)·2005
Same author

Adverse sedation events in pediatrics.

Pediatrics·2001
Same author

Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays.

Cancer research·2001
Same author

Adverse sedation events in pediatrics: analysis of medications used for sedation.

Pediatrics·2000
Same author

Capacitance cytometry: measuring biological cells one by one.

Proceedings of the National Academy of Sciences of the United States of America·2000
Same author

Adverse sedation events in pediatrics: a critical incident analysis of contributing factors.

Pediatrics·2000

This review discusses pharmacologic support for myocardial contractility, including catecholamines, amrinone, and digitalis glycosides. Proper drug selection minimizes adverse effects in critical care settings.

Area of Science:

  • Cardiology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Pharmacologic agents are crucial for enhancing myocardial contractility and managing organ blood flow in critically ill patients.
  • Understanding the risks and benefits of different drug classes is essential for optimizing patient outcomes.

Purpose of the Study:

  • To review three main categories of pharmacologic support used to enhance myocardial contractility.
  • To discuss the adverse effects associated with these agents and guide appropriate selection.

Main Methods:

  • Literature review of pharmacologic agents affecting myocardial contractility and organ blood flow.
  • Analysis of the properties, benefits, and adverse effects of catecholamines, amrinone, and digitalis glycosides.

Related Experiment Videos

Main Results:

  • Catecholamines increase cardiac work and oxygen demand, potentially causing tachycardia, dysrhythmias, and vasoconstriction.
  • Amrinone offers a favorable oxygen balance in failing ventricles without significant tachycardia or dysrhythmias, but has accumulation concerns.
  • Digitalis glycosides, while effective, present toxicity risks managed with digitalis Fab fragments for severe intoxications.

Conclusions:

  • Appropriate selection of inotropic agents is vital to minimize adverse effects in critically ill patients.
  • Each drug class (catecholamines, amrinone, digitalis) has unique risk-benefit profiles requiring careful consideration.
  • Advances in treating digitalis toxicity, such as with Fab fragments, improve patient outcomes.